Sunshine Biopharma, Inc·4/A

Oct 7, 9:04 AM ET

MERZOUKI ABDERRAZZAK 4/A

4/A · Sunshine Biopharma, Inc · Filed Oct 7, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2018-08-27
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2018-08-27$0.00/sh+38,000,000$38,000117,000,000 total

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT